AI assistant
Sending…
MESA LABORATORIES INC /CO/ — Director's Dealing 2021
Nov 16, 2021
33153_dirs_2021-11-16_1589e1b3-99a0-4c3e-8c4c-15fcb0e0ebd6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MESA LABORATORIES INC /CO/ (MLAB)
CIK: 0000724004
Period of Report: 2021-11-15
Reporting Person: Sullivan John James (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-15 | Common Stock | M | 438 | $89.7 | Acquired | 22295 | Direct |
| 2021-11-15 | Common Stock | M | 4754 | $97.78 | Acquired | 27049 | Direct |
| 2021-11-15 | Common Stock | S | 5192 | $308.02 | Disposed | 21857 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-11-15 | Non Qualified Stock Option | $89.7 | X | 438 | Disposed | 2022-04-01 | Common Stock (438) | Direct |
| 2021-11-15 | Non Qualified Stock Options | $97.78 | X | 4754 | Disposed | 2022-04-01 | Common Stock (4754) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 30000 | Indirect |
Footnotes
F1: 1/7 exercisable on each anniversary date of the 04/01/2014 grant date
F2: 1/5 exercisable on each anniversary date of the 04-01-2016 grant date
F3: Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on February 25, 2021
F4: Represents gift of shares to a spousal lifetime access trust
More from MESA LABORATORIES INC /CO/
Major Shareholding Notification
2026
Apr 15
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 23
Major Shareholding Notification
2026
Mar 13
Regulatory Filings
2026
Mar 9
Regulatory Filings
2026
Feb 3
Interim / Quarterly Report
2026
Feb 3
Director's Dealing
2025
Dec 5
Interim / Quarterly Report
2025
Nov 6
Regulatory Filings
2025
Nov 6